Evidence map›Paper›PMID 26554831›Full record

ArticlePloS one2015

Differential Regulation of 6- and 7-Transmembrane Helix Variants of μ-Opioid Receptor in Response to Morphine Stimulation.

Marino Convertino, Alexander Samoshkin, Chi T Viet, Josee Gauthier, Steven P Li Fraine, Reza Sharif-Naeini, Brian L Schmidt, William Maixner, Luda Diatchenko, Nikolay V Dokholyan

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. A "tail" of opioid receptor variants.The Journal of clinical investigation · 2017
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Marino ConvertinoBiochemistry and Biophysics Department, University of North Carolina, 120 Mason Farm Road, Chapel Hill, NC, United States of America, 27599.
Alexander SamoshkinAlan Edwards Centre for Research on Pain, McGill University, 740 Dr. Penfield Avenue, Montreal, Quebec, Canada, H3A 0G1.
Chi T VietBluestone Center for Clinic Research, New York University, New York, NY, United States of America, 10010.
Josee GauthierCenter for Pain Research and Innovation, University of North Carolina, 385 S. Columbia Street, Chapel Hill, NC, United States of America, 27599.
Steven P Li FraineDepartment of Physiology and Cell Information Systems, McGill University, 3649 Promenade Sir William Osler, Montreal, Quebec, Canada, H3G 0B1.
Reza Sharif-NaeiniDepartment of Physiology and Cell Information Systems, McGill University, 3649 Promenade Sir William Osler, Montreal, Quebec, Canada, H3G 0B1.
Brian L SchmidtBluestone Center for Clinic Research, New York University, New York, NY, United States of America, 10010.
William MaixnerCenter for Pain Research and Innovation, University of North Carolina, 385 S. Columbia Street, Chapel Hill, NC, United States of America, 27599.
Luda DiatchenkoAlan Edwards Centre for Research on Pain, McGill University, 740 Dr. Penfield Avenue, Montreal, Quebec, Canada, H3A 0G1.
Nikolay V DokholyanBiochemistry and Biophysics Department, University of North Carolina, 120 Mason Farm Road, Chapel Hill, NC, United States of America, 27599.
McGill University · CAUniversity of North Carolina at Chapel Hill · USNew York University · US

Funding

Vulvar Vestibulitis syndrome (VVS)P01NS045685 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ESSICK, GREGORY KENT · 2004 to 2014
$12.5M
The Role of Proteases and Peptides in Cancer PainR01DE019796 · NIDCR · NEW YORK UNIVERSITY · PI HARDT, MARKUS, SCHMIDT, BRIAN L · 2010 to 2014
$2.8M
Training Program for the Next Generation of Oral Health Researchers (NextGen)T90DE021986 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI EVERETT, ERIC T. · 2011 to 2017
$2.3M
Development of a Novel Class for Opioid DrugsR41DA032293 · NIDA · ALGYNOMICS, INC. · PI DIATCHENKO, LUDA, DOKHOLYAN, NIKOLAY · 2012 to 2013
$657k
Canadian Institutes of Health Research G237818/CERC32151NIDA NIH HHS 1R41DA032293-01NIDA NIH HHS R41 DA032293NIDCR NIH HHS 1T90DE021986-01NIDCR NIH HHS R01 DE019796NIDCR NIH HHS R01DE019796NIDCR NIH HHS T90 DE021986NINDS NIH HHS P01 NS045685NINDS NIH HHS P01NS045685
6 · The paper itself

Abstract

The pharmacological effect of opioids originates, at the cellular level, by their interaction with the μ-opioid receptor (mOR) resulting in the regulation of voltage-gated Ca2+ channels and inwardly rectifying K+ channels that ultimately modulate the synaptic transmission. Recently, an alternative six trans-membrane helix isoform of mOR, (6TM-mOR) has been identified, but its function and signaling are still largely unknown. Here, we present the structural and functional mechanisms of 6TM-mOR signaling activity upon binding to morphine. Our data suggest that despite the similarity of binding modes of the alternative 6TM-mOR and the dominant seven trans-membrane helix variant (7TM-mOR), the interaction with morphine generates different dynamic responses in the two receptors, thus, promoting the activation of different mOR-specific signaling pathways. We characterize a series of 6TM-mOR-specific cellular responses, and observed that they are significantly different from those for 7TM-mOR. Morphine stimulation of 6TM-mOR does not promote a cellular cAMP response, while it increases the intracellular Ca2+ concentration and reduces the cellular K+ conductance. Our findings indicate that 6TM-mOR has a unique contribution to the cellular opioid responses. Therefore, it should be considered as a relevant target for the development of novel pharmacological tools and medical protocols involving the use of opioids.

Indexed as

Analgesics, OpioidHumansModels, MolecularMorphineProtein ConformationProtein IsoformsReceptors, Opioid, muSignal TransductionAnalgesics, OpioidMorphineProtein IsoformsReceptors, Opioid, mu

Identifiers

PMID26554831
PMCPMC4640872
OpenAlexW2273830512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.